Standards for immunohistochemical imaging: A protein reference device for biomarker quantitation

Journal of Histochemistry and Cytochemistry

Volumn 58, Issue 11, 2010, Pages 1005-1014

  Atha, Donald H ^a   Manne, Upender ^b   Grizzle, William E ^b   Wagner, Paul D ^c   Srivastava, Sudhir ^c   Reipa, Vytas ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b University of Alabama at Birmingham   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer biomarker quantitation; Immunohistochemistry; Microscopy; Molecular imaging; p53; Protein immobilization; Spectroscopy; Standards

Indexed keywords

BIOLOGICAL MARKER; FLUORESCENT DYE; PROTEIN P53; GLASS; IMMOBILIZED PROTEIN;

ARTICLE; FLUORESCENCE SPECTROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICROSCOPY; MOLECULAR IMAGING; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; REPRODUCIBILITY; STANDARD; TWO DIMENSIONAL GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; CHEMISTRY; IMMUNOLOGY; INSTRUMENTATION; METABOLISM; QUALITY CONTROL; SPECTROFLUOROMETRY;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; GLASS; HUMANS; IMMOBILIZED PROTEINS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICROSCOPY; MOLECULAR IMAGING; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78149478943     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2010.956342     Document Type: Article

References (46)

1. Atha DH, Miller K, Sanow AD, Xu J, Hess JL, Wu OC, Wang W, et al. (2003) High-throughput analysis of telomerase by capillary electrophoresis. Electrophoresis 24:109-114 (Pubitemid 36175858)
2. Atha DH, Wenz H-M, Morehead H, Tian J, O'Connell C (1998) Detection of p53 point mutations by single strand conformation polymorphism: analysis by capillary electrophoresis. Electrophoresis 19:172-179 (Pubitemid 28131236)
3. Barker PE (2003) Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST). Ann NY Acad Sci 983:142-150
4. Bogen SA, Vani K, McGraw B, Fedrico V, Habib I, Zeheb R, Luther E, et al. (2009) Experimental validation of peptide immunohistochemistry controls. Appl Immunohistochem Mol Morphol 17:239-246
5. Bullock AN, Henckel J, DeDecker BS, Johnson CM, Nikolova PV, Proctor MR, Lane D, et al. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc Natl Acad Sci USA 94:14338-14342 (Pubitemid 28041374)
6. Choi J, Wang NS, Reipa V (2008) Conjugation of the photoluminescent silicon nanoparticles to streptavidin. Bioconjug Chem 19:680-685 (Pubitemid 351431400)
7. Chow V, Yuen AW, Lam K, Ho WK, Wei WI (2001) Prognostic significance of serum p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma. Head Neck 23:286-291 (Pubitemid 32234105)
8. Goldstein NS, Hewitt SM, Taylor CR, Yaziji H, Hicks DG; Members of Ad-Hoc Committee on Immunohistochemistry Standardization (2007) Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 15:124-133
9. Hess JL, Atha DH, Xu J, Highsmith WE (2004) Telomerase activity measurement in magnetically captured epithelial cells: comparison of slab-gel and capillary electrophoresis. Electrophoresis 25:1852-1859 (Pubitemid 39010753)
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
11. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ (1996) Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054-1059
12. Jakupciak JP, Barker PE, Wang W, Srivastava S, Atha DH (2005) Preparation and characterization of candidate reference materials for telomerase assays. Clin Chem 51:1443-1450 (Pubitemid 41060876)
13. Jakupciak JP, Gallant ND, Smith AH, Becker ML, Tona A, Atha DH (2009) Improved methods and standards for telomerase detection: quantitative histopathology using antibody staining. Biotech Histochem 84:195-206
14. Jakupciak JP, Wang W, Barker PE, Srivastava S, Atha DH (2004) Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells. JMol Diagn 6: 157-165 (Pubitemid 39136642)
15. Johnstone A, Thorpe R (1982) Immunochemistry in Practice. Oxford, Blackwell
16. Larsson LI, Hougaard DM (1994) Glass slide models for immunocytochemistry and in situ hybridization. Histochemistry 101:325-331
17. Ligner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567 (Pubitemid 27193675)
18. Manne U (2007) Understanding racial differences in colorectal cancer aids in individualized medicine. Future Oncol 3:235-241 (Pubitemid 47022843)
19. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, et al. (1997a) Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74:346-358 (Pubitemid 27321807)
20. Manne U, Myers RB, Srivastava S, Grizzle WE (1997b) Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 89:585-586
21. Manne U, Weiss HC, Myers RB, Danner OK, Moron C, Srivastava S, Grizzle WE (1998) Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 83:2456-2467 (Pubitemid 29019563)
22. Martin-Rivera L, Basco MA (2001) Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J Biol Chem 276:5856-5865
23. Merrick BA, ZhouW, Martin KJ, Jeyarajah S, Parker CE, Selkirk JK, Tomer KB, et al. (2001) Site-specific phosphorylation of human p53 protein determined by mass spectrometry. Biochemistry 40:4053-4066 (Pubitemid 32280443)
24. Michaud GY (2005) The role of standards in the development and implementation of clinical laboratory test: a domestic and global perspective. Cancer Biomark 1:207-208
25. Millar DA, Williams ED (1982) A step-wedge standard for the quantification of immunoperoxidase techniques. Histochem J 14:609-620
26. Nibbering PH, van Furth R (1987) Microphotometric quantitation of the reaction product of several indirect immunoperoxidase methods demonstrating monoclonal antibody binding to antigens immobilized on nitrocellulose. J Histochem Cytochem 35:1425-1431
27. O'Connell CD, Atha DH, Jakupciak JP (2005) Standards for validation of cancer biomarkers. Cancer Biomark 1:233-239
28. O'Connell CD, Tian J, Juhasz A, Wenz H-M, Atha DH (1998) Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism. Electrophoresis 19:164-171 (Pubitemid 28131235)
29. O'Connell CD, Tully LA, Devaney JM, Marino MA, Jakupciak JP, Atha DH (2003) Renewable standard reference material for the detection of TP53 mutations. Mol Diagn 7:85-97
30. Otali D, Stockard C, Oelschlager D, Wan W, Manne U, Watts SA, Grizzle WE (2009) Combined effects of formalin fixation and tissue processing on immuno-recognition. Biotech Histochem 84:223-247
31. Piyathilake CJ, Frost AR, Manne U, Weiss H, Heimburger DC, Grizzle WE (2003) Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers. Chest 123:181-186 (Pubitemid 36131111)
32. Prioleau J, Schnitt SJ (1995) p53 antigen loss in stored paraffin slides. N Engl J Med 332:1521-1522
33. Roberts CJ, Williams PM, Davies J, Dawkes AC, Sefton J (1995) Real space differentiation of IgG and IgM antibodies deposited on microtiter wells by scanning force microscopy. Langmuir 11:1822-1826
34. Sompuram SR, Kodela V, Zhang K, Ramanathan H, Radcliffe G, Falb P, Bogen SA (2002) A novel quality control slide for quantitative immunohistochemistry testing. J Histochem Cytochem 50:1425-1433 (Pubitemid 36024889)
35. Sunar-Reeder B, Atha DH, Aydemir S, Reeder DJ, Tully L, Khan AR, O'Connell CD (2004) Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-strand conformational polymorphism analysis. Mol Diagn 8:123-130 (Pubitemid 39363467)
36. Taylor CR (1992) Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the Biological Stain Commission, June, 1991. Biotech Histochem 67:110-117
37. Taylor CR (2000) The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med 124:945-951
38. Taylor CR (2007) Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis. J Histochem Cytochem 55:105-109
39. Tidow H, Melero R, Mylonas E, Freund SM, Grossmann JG, Caraso JM, Svergun D, et al. (2007) Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci USA 104:12324-12329 (Pubitemid 47206136)
40. Tothill IE (2009) Biosensors for cancer markers diagnosis. Semin Cell Dev Biol 20:55-62
41. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523-526
42. Wang L, Reipa V, Blasic J (2004) Silicon nanoparticles as a luminescent label to DNA. Bioconjug Chem 15:409-412 (Pubitemid 38365203)
43. Weetall HH (1993) Preparation of immobilized proteins covalently coupled though silane coupling agents to inorganic supports. Appl Biochem Biotechnol 41:157-188
44. Wenz H-M, Ramachandra S, O'Connell CD, Atha DH (1998) Identification of known p53 point mutations by capillary electrophoresis using unique mobility profiles in a blinded study. Mutat Res 382:121-132
45. Willamson ML, Atha DH, Reeder DJ, Sundaram PV (1989) Anti-T2 monoclonal antibody immobilization on quartz fibers: stability and recognition of T2 mycotoxin. Anal Lett 22:803-816
46. Wright K, Thompson MR (1975) Hydrodynamic structure of bovine serum albumin determined by birefringence. Biophys J 15:137-141